使用增强HDR的DNA-PKcs抑制剂AZD7648进行基因组编辑会导致大规模的基因组改变
Grégoire Cullot1, Eric J Aird2, Moritz F Schlapansky2
1Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland. gregoire.cullot@biol.ethz.ch.
Nature biotechnology
|November 28, 2024
概括
DNA-PKcs 抑制剂 AZD7648 增强了 CRISPR-Cas9 基因编辑,但导致了大量的,未被发现的 DNA 删除和重排. 在临床使用这种DNA修复增强剂之前,进一步的安全评估至关重要.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- CRISPR-Cas9是一种强大的基因编辑工具.
- 同质定向修复 (HDR) 提高了编辑精度.
- 像AZD7648这样的DNA-PKcs抑制剂可以增强HDR,但它们的安全性尚不清楚.
研究的目的:
- 调查AZD7648在CRISPR-Cas9介导的HDR中的目标效应.
- 评估由AZD7648.8.引起的基因组变化的类型和规模.
主要方法:
- 在相关细胞模型中利用CRISPR-Cas9基因编辑.
- 在编辑过程中使用DNA-PKcs抑制剂AZD7648.
- 采用全基因组测序和细胞遗传分析来检测大规模的基因组变化.
主要成果:
- 治疗AZD7648导致频繁的大型删除 (千基至兆基规模).
- 观察到显著的染色体异常,包括手臂损失和转位.
- 这些广泛的改变没有被标准的基因编辑分析方法检测到.
结论:
- AZD7648可以诱导实质性的,潜在的有害的,针对目标的基因组重组.
- 当前的标准测试可能无法识别这些大规模编辑后果.
- 建议在使用AZD7648时谨慎使用,需要对各种编辑结果进行全面分析.
相关概念视频
01:59CRISPR
49.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.5K
02:31Homologous Recombination
50.2K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.2K